Abstract:Hypoxia is a hallmark of solid tumors. Hypoxic cancer cells adjust their metabolic characteristics to regulate the production of cellular reactive oxygen species (ROS) and facilitate ROS‐mediated metastasis. Peroxisome proliferator‐activated receptor γ (PPARγ) is a nuclear receptor that regulates the transcription of fatty acid metabolism‐related genes that have a key role in the survival and proliferation function of hypoxic cancer cells. In the present study, mRNA expression in HepG2 cells under chemically induced hypoxia was assessed. The protein expression levels of hypoxia‐inducible factor 1α (HIF‐1α) were measured using western blotting. Following treatment with the PPARγ agonist pioglitazone, cell viability was assessed using a Cell Counting Kit‐8 assay, whilst cell proliferation and death were determined using 5‐ethynyl‐2'‐deoxyuridine incorporation staining, and calcein‐acetoxymethyl ester and propidium iodide staining, respectively. Cellular ROS production was assessed using dihydroethidium staining. Cobalt chloride was used to induce hypoxia in HepG2 cells, which was evaluated using HIF‐1α expression. The results revealed that the mRNA expression of PPARγ, CD36, acetyl‐co‐enzyme A dehydrogenase (ACAD) medium chain (ACADM) and ACAD short‐chain (ACADS) was downregulated in hypoxic HepG2 cells. The PPARγ agonist pioglitazone decreased the cell viability of hypoxic HepG2 cells by inhibiting cell proliferation and inducing cell death. Following treatment with the PPARγ agonist pioglitazone, hypoxic HepG2 cells produced excessive ROS. ROS‐mediated cell death induced by the PPARγ agonist pioglitazone was rescued with the antioxidant N‐acetyl‐L‐cysteine. The downregulated mRNA expression of PPARγ, CD36, ACADM and ACADS was not reverted by a PPARγ agonist in hypoxic HepG2 cells. By contrast, the PPARγ agonist suppressed the mRNA expression of BCL2, which was upregulated in hypoxic HepG2 cells. In summary, the PPARγ agonist stimulated excessive ROS production to inhibit cell proliferation and increase the death of hypoxic HepG2 cells by decreasing BCL2 mRNA expression, suggesting a negative association between PPARγ and BCL2 in the regulation of ROS production in hypoxic HepG2 cells.

Peroxisome Proliferator-Activated Receptor Γ Ligands Induce Apoptosis of Renal Cell Carcinoma

[Peroxisome Proliferator-Actived Receptor-Gamma Ligand Troglitazone Induces Apoptosis in Renal Cell Carcinoma].

Peroxisome Proliferator-Activated Receptor Γ Ligands Induce Cell Cycle Arrest and Apoptosis in Human Renal Carcinoma Cell Lines

Iufluence of peroxisome proliferator-activated receptor γ(PPARγ) ligands on angiogenesis in renal cell carcinoma

Pioglitazone, a peroxisome proliferator‐activated receptor γ agonist, induces cell death and inhibits the proliferation of hypoxic HepG2 cells by promoting excessive production of reactive oxygen species

Peroxisome proliferator-activated receptor γ agonist pioglitazone inhibits glioma cell growth mediated by β-catenin

[Effects of Peroxisome Proliferator-Activated Receptor-Gamma Ligand Troglitazone on Colon Cancer Cell Growth].

Effect of Peroxisome Proliferator-Activated Receptor Γ Agonist on Prostate Epithelial Cells

Pioglitazone mediates apoptosis in Caki cells via downregulating c-FLIP(L) expression and reducing Bcl-2 protein stability

Expression of Peroxisome Proliferator-actived Receptor Γ in Renal Cell Carcinoma

Curcumin Suppresses PPARδ Expression and Related Genes in HT-29 Cells

PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells.

Glucocorticoid Receptor Activation Inhibits P53-Induced Apoptosis of MCF10Amyc Cells Via Induction of Protein Kinase Cϵ

PPARgamma ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway.

PPARG Negatively Modulates Six2 in Tumor Formation of Clear Cell Renal Cell Carcinoma.

Troglitazone Sensitizes Effect of Epirubicin on Breast Cancer Cells

Down-regulation of X-linked Inhibitor of Apoptosis Synergistically Enhanced Peroxisome Proliferator-Activated Receptor Γ Ligand-Induced Growth Inhibition in Colon Cancer

Activation of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) inhibits human breast cancer cell line tumorigenicity

PPARγ Ligands Inhibit Cholangiocarcinoma Cell Growth Through P53-Dependent GADD45 and P21waf1/cip1 Pathway

Pachymic acid activates TP53INP2/TRAF6/caspase‐8 pathway to promote apoptosis in renal cell carcinoma cells

The Ppar Gamma Agonist Troglitazone Induces Autophagy, Apoptosis And Necroptosis In Bladder Cancer Cells